To assess and compare the impact of catheter ablation versus antiarrhythmic drug therapy on health-related quality of life in patients with atrial fibrillation.
Randomized clinical trial (EudraCT: 2008-001384-11) comparing catheter ablation to medical therapy.
Evaluated patient-reported quality-of-life metrics and arrhythmia outcomes in individuals diagnosed with atrial fibrillation.
Investigated relative improvements in disease-specific and general quality-of-life measures between catheter ablation and antiarrhythmic pharmacotherapy.